
Biovie Inc (BIVI)
US$ 1.08-6.9%
Price Chart
Key Statistics
Market Cap
$ 21.04M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
944.88K
52W High
$ 5.08
52W Low
$ 0.62
Dividend Yield
0.00%
Beta
1.18
Technicals
50-Day MA
1.0104
200-Day MA
2.1175
52 Week High
5.077
52 Week Low
0.62
About BIVI
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease.
Employees
14
Headquarters
Carson City, NV
CEO
Mr. Cuong Viet Do M.B.A.
Latest News
BioVie (BIVI) Showcases Parkinson's Trial at Global Conference | BIVI Stock News - GuruFocus
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg